BlackRock Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.04M Buy
21,161
+1,321
+7% +$72.9K ﹤0.01% 2109
2016
Q3
$1.19M Buy
19,840
+935
+5% +$50.2K ﹤0.01% 1938
2016
Q2
$661K Sell
18,905
-189
-1% -$8.23K ﹤0.01% 2156
2016
Q1
$785K Buy
19,094
+3,577
+23% +$140K ﹤0.01% 2048
2015
Q4
$1.06M Buy
15,517
+2,099
+16% +$127K ﹤0.01% 1864
2015
Q3
$608K Buy
13,418
+6,320
+89% +$368K ﹤0.01% 2125
2015
Q2
$374K Sell
7,098
-1,393
-16% -$55K ﹤0.01% 2367
2015
Q1
$324K Buy
8,491
+2,006
+31% +$51.5K ﹤0.01% 2338
2014
Q4
$135K Sell
6,485
-9,684
-60% -$202K ﹤0.01% 2608
2014
Q3
$358K Sell
16,169
-9,875
-38% -$209K ﹤0.01% 2289
2014
Q2
$587K Buy
+26,044
New +$651K ﹤0.01% 2136
2013
Q4
Sell
-2,012
Closed -$41K 2759
2013
Q3
$41K Buy
2,012
+1,658
+468% +$29.3K ﹤0.01% 2732
2013
Q2
$5K Buy
+354
New +$3.29K ﹤0.01% 2594

Other funds holding PRTA

BlackRock Group's PRTA Position: Q4 2016 in Review

BlackRock Group increased its Prothena Corp (PRTA) stake by 6.7% in Q4 2016, buying an estimated $72.9K and bringing the position to 21,161 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

BlackRock Group first reported a position in PRTA in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.19M in Q3 2016. 145 funds tracked by Wall St. Rank hold PRTA as of Q4 2016.

  • BlackRock Group held 21,161 shares of Prothena Corp worth $1.04M as of Q4 2016.
  • BlackRock Group bought 1,321 Prothena Corp shares in Q4 2016, an estimated $72.9K.
  • Prothena Corp made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2109 holding.
  • BlackRock Group first reported a position in Prothena Corp in Q2 2013 and has held it in 13 quarters since.
  • BlackRock Group's Prothena Corp position peaked at $1.19M in Q3 2016.
  • 145 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.